Safety, Efficacy and Pharmacokinetic Study of Dexmedetomidine in Pediatrics Ages ≥28 Weeks to ≤44 Weeks Gestational Age

NCT01159262 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Sedation

Interventions

DRUG: Midazolam
DRUG: Fentanyl/Morphine
DRUG: Dexmedetomidine

Sponsor

Hospira, now a wholly owned subsidiary of Pfizer